A soluble interleukin 6 receptor isolated from conditioned medium of human breast cancer cells is encoded by a differentially spliced mRNA

Cytokine

Volumn 8, Issue 5, 1996, Pages 401-409

  Oh, Jae Wook ^a   Revel, Michel ^a   Chebath, Judith ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cancer cells; Differential splicing; IL 6 agonist; Soluble IL 6 receptor

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6 RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CHO CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; RNA SPLICING; SIGNAL TRANSDUCTION;

EID: 0029896751     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0055     Document Type: Article

References (49)

1. Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T (1988) Cloning and expression of the human Interleukin-6 (BSF-2/Interferon beta-2) receptor. Science 241:825-828.
2. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573-581.
3. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T (1990) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63:1149-1157.
4. Yasukawa, K, Saito T, Fukunaga T, Sekimori Y, Koishihara Y, Fukui H, Ohsugi Y, Matsuda, Yawata H, Hirano TT (1990) Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J Biochem (Tokyo) 108:673-676.
5. Novick D, Englemann, M, Revel M, Leitner O and Rubinstein M (1991) Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 10:137-146.
6. Novick D, Shulman LM, Chen L and Revel M (1992) Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. Cytokine 4:6-11.
7. Novick D, Engelmann H, Wallach D, Leitner O, Revel M, Rubinstein M (1990) Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography. J Chromatogr 510:331-337.
8. Gaillard, Bataille R, Brailly H, Zuber C, Yasukawa K, Attal M, Mauro N, Taga T, Kishimoto T, Klein B (1993) Increased and highly stable levels of functional soluble interleukin-6 reeptor in sera of patients with monoclonal gammopathy. Eur J Immunol 23:820-824.
9. Mullberg J, Schooltink H, Stoyan T, Gunther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose JS (1993) The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23:473-480.
10. Mullberg J, Oberthur W, Lottspeich F, Mehl E, Dittrich E, Graeve L, Heinrich PC, Rose JS (1994) The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J Immunol 152:4958-4968.
11. Lust JA, Donovan KA, Kline MP, Greipp PR, Kyle RA Maihle NJ (1992) Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4:96-100.
12. Korholz D, Nussbaum P, Pafferath B, Mauz-Korholz C, Hempel L, Burdach S (1994) Activation of protein kinase C induces de novo synthesis of the soluble interleukin 6 receptor in human B cells. Scan J Immunol 40:515-520.
13. Horiuchi S, Koyanagi Y, Zhou Y, Miyamoto H, Tanaka Y, Waki M, Matsumoto A, Yamamoto MY, Yamamoto N (1994) Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol 24:1945-1948.
14. Chen L, Shulman LM, Revel M (1991) IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells. J Biol Regul Homeost Agents 5:125-136.
15. Chen L, Mory Y, Zilberstein A, Revel M (1988) Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2. Proc Natl Acad Sci USA 85:8037-8041.
16. Urlaub G, Chasin LA (1980) Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity. Proc Natl Acad Sci USA 77:4216-4220.
17. Chomczynski, Sacchi N (1987) Single step method of RNA isolation by acid guanidinium-Thiocyanate-Phenol-chloroform extraction. Anal Biochem 162:156-159.
18. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular Cloning: A Laboratory manual.
19. Dirks W, Schaper F, Hauser H (1994) A new hybrid promoter directs transcription at identical start points in mammalian cells and in vitro. Gene 149:389-390.
20. Harroch S, Revel M, Chebath J (1994) Interleukin-6 signaling via four transcription factors binding palindromic enhancers of different genes. J Biol Chem 269:26191-26195.
21. Stoyan T, Michaelis U, Schooltink H, Van DM, Rudolph R, Heinrich PC, Rose JS (1993) Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification. Eur J Biochem 216:239-245.
22. Paonessa G, Graziani R, De Serio A, Savino R, Ciapponi L, Lahm A, Salvati AL, Toniatti C, Cilinerto G (1995) Two distincts and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J. 14:1942-1951.
23. Ward LD, Howlett GJ, Discolo G, Yasukawa K, Hammacher A, Moritz RL, Simpson RJ (1994) High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol Chem 269:23286-23289.
24. Savino R, Lahm A, Salvati AL, Ciapponi L, Sporeno E, Altamura S, Paonessa G, Toniatti C, Ciliberto G (1994) Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. Embo J 13:1357-1367.
25. Savino R, Lahm A, Giorgio M, Cabibbo A, Tramontano A, Ciliberto G (1993) Saturation mutagenesis of the human interleukin 6 receptor-binding site: implications for its three-dimensional structure. Proc Natl Acad Sci USA 90:4067-4071.
26. Wegenka UM, Lutticken C, Buschmann J, Yuan JP, Lottspeich F, Mulleresterl W, Schindler C, Roeb E, Heinrich PC, Horn F (1994) The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (stat) family. Mol Cell Biol 14:3186-3196.
27. Zhong Z, Wen ZL, Darnell JE (1994) Stat3 - a stat family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98.
28. Harroch S, Revel M, Chebath J (1994) Induction by interleukin-6 of interferon regulatory factor 1 (IRF-1) gene expression through the palindromic interferon response element pIRE and cell type-dependent control of IRF-1 binding to DNA. Embo J 13:1942-1949.
29. Akira S, Nishio Y, Inoue M, Wang XJ, Wei S, Matsusaka T, Yoshida K, Sudo T, Naruto M, Kishimoto T (1994) Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77:63-71.
30. Suzuki H, Yasukawa K, Saito T, Narazaki M, Hasegawa A, Taga T, Kishimoto T (1993) Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. Eur J Immunol 23:1078-1082.
31. De Benedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A (1994) Serum soluble interleukin 6 (IL-6) receptor and IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 93:2114-2119.
32. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suzuki H, Saito T Osugi Y, Tokunaga T, Kishimoto (1992) Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 148:2175-2180.
33. Kishimoto T (1989) The biology of interleukin-6. Blood 74:1-10.
34. Revel M, Zilberstein A, Chen L, Gothelf Y, Barash I, Novick D, Rubinstein M, Michalevicz R ( 1989) Biological activities of recombinant human IFN-beta 2/IL-6 (E. coli). Ann NY Acad Sci 557:144-155.
35. Shabo Y, Lotem J, Rubinstein M, Revel M, Clark SC, Wolf SF, Kamen R, Sachs L (1988) The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood 72:2070-2073.
36. Nichols J, Chambers I, Smith A (1994) Derivation of germline competent embryonic stem cells with a combination of interleukin-6 and soluble interleukin-6 receptor. Exp Cell Res 215:237-239.
37. Yoshida K, Chambers I, Nichols J, Smith A, Saito M, Yasukawa K, Shoyab M, Taga T, Kishimoto T (1994) Maintenance of the pluripotential phenotype of embryonic stem cell through direct activation of gp130 signalling pathways. Mech Dev 45:163-171.
38. Marinkovic S, Jahreis GP, Wong GG, Baumann H (1989) IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo. J Immunol 142:808-812.
39. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H (1987) Interferon-beta2/B-cell stimulatory factor type 2 shares identity with monocyte derived hepatocyte stimulatingfactor and regulates the major acute cell protein response in liver cells. Proc Natl Acad Sci USA 84:7251-7256.
40. Lu C, Vickers MF, Kerbel RS (1992) Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression. Proc Natl Acad Sci USA 89:9215-9219.
41. Katz A, Shulman LM, Porgador A, Revel M, Feldman M, Eisenbach L (1993) Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy. J Immunother 13:98-109.
42. Marcus SG, Perrylalley D, Mule JJ, Rosenberg SA, Yang JC (1994) The use of interleukin-6 to generate tumor-infiltrating lymphocytes wih enhanced in vivo antitumor activity. Journal of Immunotherapy 15:105-112.
43. Hirano T (1991) Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias. Int J Cell Cloning 9:166-14.
44. Joshua DE, Gibson J, Brown RD (1994) Mechanisms of the escape phase of myeloma. Blood Rev 8:13-20.
45. Ershler WB (1993) Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc 41:176-181.
46. Fattori E, Della RC, Costa P, Giorgio M, Dente B, Pozzi L, Ciliberto G (1994) Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 83:2570-2579.
47. de HF, Ehlers M, Rose JS, Ebeling SB, Bos HK, Aarden LA, Brakenhoff JP (1994) Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells. J Exp Med 180:2395-2400.
48. Frieling JT, Wijdenes J, Clement C, Sauerwein RW (1995) Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infact Dis 171:469-472.
49. Narazaki M, Yasukawa, Saito T, Ohsugi Y, Fukui H, Koishihara, Yancopoulos GD, Taga T, Kishimoto T (1993) Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82:1120-1126.